Jerusalem Pharmaceuticals Co. Ltd.'s latest marketcap:
As of 07/05/2025, Jerusalem Pharmaceuticals Co. Ltd.'s market capitalization has reached $71.99 M. According to our data, Jerusalem Pharmaceuticals Co. Ltd. is the 27048th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 71.99 M |
| Revenue (ttm) | 41.87 M |
| Net Income (ttm) | 6.86 M |
| Shares Out | 18 M |
| EPS (ttm) | 0.38 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 04/30/2025 |
| Earnings Date | 08/10/2025 |
Jerusalem Pharmaceuticals Co. Ltd.'s yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | د.أ71.99 M | 4.28% | 27048 |
| 12/24/2024 | د.أ48.95 M | 0.78% | 25761 |
| 12/31/2023 | د.أ48.57 M | 15.89% | 25639 |
| 12/29/2022 | د.أ41.91 M | 16.1% | 25771 |
| 12/23/2021 | د.أ36.1 M | 2.12% | 27423 |
| 12/31/2020 | د.أ35.35 M | -1.04% | 24713 |
| 12/31/2019 | د.أ35.72 M | -13.67% | 21905 |
| 12/31/2018 | د.أ41.38 M | -0.6% | 20145 |
| 12/31/2017 | د.أ41.63 M | 81.34% | 20741 |
| 12/29/2016 | د.أ22.96 M | -4.63% | 21388 |
Company Profile
About Jerusalem Pharmaceuticals Co. Ltd.
Jerusalem Pharmaceuticals Co. Ltd. is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of a diverse range of healthcare products. Established in 1969 and headquartered in Ramallah, Palestinian Authority, the company serves markets across Palestine, the Middle East, North Africa, and internationally.
Product Portfolio
The company offers a comprehensive selection of pharmaceutical and wellness products, including:
- Over-the-counter (OTC) medications
- Prescription pharmaceuticals
- Nutritional supplements
Manufacturing Capabilities
Jerusalem Pharmaceuticals produces approximately 300 pharmaceutical products in various dosage forms, such as:
- Tablets & capsules
- Sterile injectables
- Suspensions & syrups
- Powders, suppositories, and ovules
- Creams, ointments, and topical solutions
- Ear and nose drops
Additional Product Lines
Beyond pharmaceuticals, the company also manufactures:
- Detergents & cleaning products
- Cosmetics & personal hygiene items
- Veterinary medicines
- Agricultural products
Frequently Asked Questions
-
What is Jerusalem Pharmaceuticals Co. Ltd.'s (PEX-JPH) current market cap?As of 07/05/2025, Jerusalem Pharmaceuticals Co. Ltd. (including the parent company, if applicable) has an estimated market capitalization of $71.99 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Jerusalem Pharmaceuticals Co. Ltd. (PEX-JPH) rank globally by market cap?Jerusalem Pharmaceuticals Co. Ltd. global market capitalization ranking is approximately 27048 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.